PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Cell and Gene Therapy

Upcoming Events

SLAS Europe – 7th April 2025
Biotechnology Show 2025: 20th January 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025

Virus-like particles: Versatile platforms

Vaccination represents, together with the supply of fresh water, the most efficient tool to prevent infectious diseases in human. Vaccines` power is undeniable, ever since the worldwide eradication of smallpox in the 1970s. Besides their high efficacy, the conventional dead or live-attenuated vaccines suffer substantial drawbacks, especially regarding their safety. David Wetzel at ARTES Biotechnology GmbH and Jo-Anne Chan at Burnet Institute, Melbourne explain why the risk of incomplete inactivation or reversion to virulence cause tragic adverse effects in individual cases.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/11/Virus-like-particles_-Versatile-platforms.pdf” width=”100%” height=”900px” style=”border:0;”]

Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Tosoh – 29.04.25
Eppendorf – 18.03.2025
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025